Nicholas F. Grigoropoulos

714 total citations
14 papers, 169 citations indexed

About

Nicholas F. Grigoropoulos is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Nicholas F. Grigoropoulos has authored 14 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 4 papers in Neurology. Recurrent topics in Nicholas F. Grigoropoulos's work include Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (4 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Nicholas F. Grigoropoulos is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (4 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Nicholas F. Grigoropoulos collaborates with scholars based in Singapore, United Kingdom and Taiwan. Nicholas F. Grigoropoulos's co-authors include K. George Chandy, Vishal G. Shelat, Shane P. Duggan, Navin Kumar Verma, Zhi Sheng Poh, George Follows, Mike Scott, Mars B. van ’t Veer, Soon Thye Lim and Russell C. Petter and has published in prestigious journals such as Blood, Clinical Cancer Research and BMJ.

In The Last Decade

Nicholas F. Grigoropoulos

13 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas F. Grigoropoulos Singapore 7 76 55 41 41 28 14 169
Hong Ren China 7 77 1.0× 68 1.2× 101 2.5× 52 1.3× 16 0.6× 11 242
Pingyong Yi China 9 75 1.0× 72 1.3× 40 1.0× 35 0.9× 9 0.3× 14 149
Harry Miao United States 9 104 1.4× 64 1.2× 28 0.7× 16 0.4× 23 0.8× 33 149
Ricardo Fernández‐de‐Misa Spain 8 113 1.5× 73 1.3× 58 1.4× 31 0.8× 18 0.6× 25 233
Jennifer A. Arzt United States 4 52 0.7× 58 1.1× 64 1.6× 27 0.7× 9 0.3× 5 151
Sarah E. Arthur Canada 6 57 0.8× 80 1.5× 71 1.7× 31 0.8× 8 0.3× 11 198
J.T. Greene United States 6 93 1.2× 20 0.4× 67 1.6× 66 1.6× 7 0.3× 11 169
Brendan W. MacNabb United States 7 144 1.9× 67 1.2× 52 1.3× 160 3.9× 8 0.3× 8 256
Boyu Hu United States 9 122 1.6× 99 1.8× 64 1.6× 52 1.3× 11 0.4× 34 210
Isaias Hernández-Verdín France 6 103 1.4× 25 0.5× 38 0.9× 95 2.3× 22 0.8× 14 186

Countries citing papers authored by Nicholas F. Grigoropoulos

Since Specialization
Citations

This map shows the geographic impact of Nicholas F. Grigoropoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas F. Grigoropoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas F. Grigoropoulos more than expected).

Fields of papers citing papers by Nicholas F. Grigoropoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas F. Grigoropoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas F. Grigoropoulos. The network helps show where Nicholas F. Grigoropoulos may publish in the future.

Co-authorship network of co-authors of Nicholas F. Grigoropoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas F. Grigoropoulos. A scholar is included among the top collaborators of Nicholas F. Grigoropoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas F. Grigoropoulos. Nicholas F. Grigoropoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ding, Ling‐Wen, Jia Li, Benedict Yan, et al.. (2024). A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical Cancer Research. 30(10). 2170–2180. 1 indexed citations
2.
Chan, Jason Yongsheng, Nagavalli Somasundaram, Nicholas F. Grigoropoulos, et al.. (2023). Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations. Discover Oncology. 14(1). 132–132. 9 indexed citations
3.
Grigoropoulos, Nicholas F., et al.. (2022). Role of PET imaging in peritoneal involvement of subcutaneous panniculitis-like T-cell lymphoma. Journal of Radiology Case Reports. 16(6). 1–11.
4.
Verma, Navin Kumar, Zhi Sheng Poh, Shane P. Duggan, et al.. (2022). Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint. EBioMedicine. 83. 104216–104216. 77 indexed citations
5.
Chen, Yunxin, Shin Yeu Ong, Chandramouli Nagarajan, et al.. (2021). HEMATOPOIETIC STEM CELL TRANSPLANT IN AGGRESSIVE T AND NK/T CELL LYMPHOMA - ROLE OF UPFRONT AUTOLOGOUS TRANSPLANT IN NODAL PERIPHERAL T-CELL LYMPHOMA. PubMed. 4(4). 92–100. 3 indexed citations
6.
Ong, Shin Yeu, Sanjay De Mel, Nicholas F. Grigoropoulos, et al.. (2021). High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma. Blood Cancer Journal. 11(8). 143–143. 17 indexed citations
8.
Phipps, Colin, Yuh Shan Lee, Ying Hao, et al.. (2018). The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma. Leukemia & lymphoma. 59(10). 2336–2341. 13 indexed citations
9.
Chen, Yunxin, Chandramouli Nagarajan, Nicholas F. Grigoropoulos, et al.. (2018). Impact of Incomplete Cycles and Dose Attenuation of Rituximab-Bendamustine on Survival Outcomes in Low-Grade Non-Hodgkin Lymphomas. Blood. 132(Supplement 1). 4165–4165. 1 indexed citations
10.
Nagarajan, Chandramouli, Nicholas F. Grigoropoulos, S. Gopalakrishnan, et al.. (2017). VALIDATION OF THE CNS INTERNATIONAL PROGNOSTIC INDEX IN A LARGE ASIAN COHORT–DATA FROM THE SINGAPORE LYMPHOMA STUDY GROUP. Hematological Oncology. 35(S2). 197–198. 1 indexed citations
11.
Collins, Anne T., Chandan Saha, Vidyarani Shyamsundar, et al.. (2017). Advanced Hodgkin lymphoma in the east of England cancer network: A 10‐year comparative analysis of outcomes for ABVD and escalated‐BEACOPP treated patients aged 16 to 59. Hematological Oncology. 35(S2). 318–319. 1 indexed citations
12.
Wang, Ming, Leire Escudero‐Ibarz, Sarah Moody, et al.. (2015). Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing. Journal of Molecular Diagnostics. 17(5). 521–532. 18 indexed citations
13.
Grigoropoulos, Nicholas F., Russell C. Petter, Mars B. van ’t Veer, Mike Scott, & George Follows. (2013). Leukaemia update. Part 1: diagnosis and management. BMJ. 346(mar28 4). f1660–f1660. 14 indexed citations
14.
Grigoropoulos, Nicholas F., Andrew Hodson, Ashley Shaw, et al.. (2012). Interim PET Scan Does Not Predict Outcome in Primary Mediastinal B Cell Lymphoma Treated with R DA EPOCH. Blood. 120(21). 4846–4846. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026